Atricure Stock In The News
ATRC Stock | USD 23.05 0.12 0.52% |
The overall news coverage of AtriCure from major news outlets shows bullish sentiment on 8 news articles, blog posts, and TV commentaries analyzed in the last few months. Our overall analysis of AtriCure's news coverage and content from conventional and social sources shows investors' bearish mood towards AtriCure. The specific impact of AtriCure news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of AtriCure's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using AtriCure headlines in addition to utilizing other, more conventional financial analysis modules. Check out AtriCure Backtesting and AtriCure Hype Analysis. For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.
AtriCure |
AtriCure Today Top News and Investor Outlook
AtriCure Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide AtriCure and other traded companies coverage. We help investors stay connected with AtriCure headlines for the 24th of April to make an informed investment decision based on correlating the impacts of news items on AtriCure Stock performance. Please note that trading solely based on the AtriCure hype is not for everyone as timely availability and quick action are needed to avoid losses.AtriCure stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the AtriCure earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about AtriCure that are available to investors today. That information is available publicly through AtriCure media outlets and privately through word of mouth or via AtriCure internal channels. However, regardless of the origin, that massive amount of AtriCure data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of AtriCure news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of AtriCure relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to AtriCure's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive AtriCure alpha.
AtriCure Largest EPS Surprises
Earnings surprises can significantly impact AtriCure's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2013-08-01 | 2013-06-30 | -0.1 | -0.09 | 0.01 | 10 | ||
2012-08-02 | 2012-06-30 | -0.07 | -0.08 | -0.01 | 14 | ||
2011-11-01 | 2011-09-30 | -0.08 | -0.07 | 0.01 | 12 | ||
2011-08-02 | 2011-06-30 | -0.05 | -0.06 | -0.01 | 20 | ||
2011-05-04 | 2011-03-31 | -0.07 | -0.08 | -0.01 | 14 | ||
2013-10-29 | 2013-09-30 | -0.15 | -0.13 | 0.02 | 13 |
AtriCure Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to AtriCure Stock. The global stock market is bearish. About 60% of major world exchanges and indexes are down. See today's market update for more information.23rd of April 2024
AtriCure stock upgraded at Oppenheimer at seekingalpha.com
18th of April 2024
AtriCure launches new cryoablation probe at massdevice.com
16th of April 2024
AtriCure Reaches New 52-Week Low at 22.42 - MarketBeat at news.google.com
10th of April 2024
AtriCure to Announce First Quarter 2024 Financial Results at businesswire.com
1st of April 2024
Disposition of 1500 shares by Justin Noznesky of AtriCure at 30. subject to Rule 16b-3 at MacroaxisInsider
27th of March 2024
AtriCure Cut to Sell at StockNews.com - MarketBeat at news.google.com
25th of March 2024
Tricares Announces the Appointment of Ahmed Elmouelhi as President Chief Executive Officer at finance.yahoo.com
22nd of March 2024
AtriCure Declined due to Concerns Over Anti-Obesity Drug at finance.yahoo.com
19th of March 2024
AtriCure 2Q Earnings Snapshot - Yahoo Movies UK at news.google.com
28th of February 2024
AtriCure Fell on Competitor Action at finance.yahoo.com
15th of February 2024
AtriCure Reports Fourth Quarter 2023 and Full Year 2023 Financial Results at businesswire.com
AtriCure Investors Sentiment
The influence of AtriCure's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in AtriCure. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to AtriCure's public news can be used to forecast risks associated with an investment in AtriCure. The trend in average sentiment can be used to explain how an investor holding AtriCure can time the market purely based on public headlines and social activities around AtriCure. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
AtriCure's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for AtriCure's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average AtriCure's news discussions. The higher the estimated score, the more favorable is the investor's outlook on AtriCure.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AtriCure in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AtriCure's short interest history, or implied volatility extrapolated from AtriCure options trading.
Check out AtriCure Backtesting and AtriCure Hype Analysis. For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for AtriCure Stock analysis
When running AtriCure's price analysis, check to measure AtriCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AtriCure is operating at the current time. Most of AtriCure's value examination focuses on studying past and present price action to predict the probability of AtriCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AtriCure's price. Additionally, you may evaluate how the addition of AtriCure to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Is AtriCure's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AtriCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.66) | Revenue Per Share 8.621 | Quarterly Revenue Growth 0.21 | Return On Assets (0.03) | Return On Equity (0.07) |
The market value of AtriCure is measured differently than its book value, which is the value of AtriCure that is recorded on the company's balance sheet. Investors also form their own opinion of AtriCure's value that differs from its market value or its book value, called intrinsic value, which is AtriCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AtriCure's market value can be influenced by many factors that don't directly affect AtriCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AtriCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if AtriCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AtriCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.